01622nam 2200397 450 991058338990332120230120002804.00-323-54950-00-323-54948-9(CKB)4100000006096048(MiAaPQ)EBC5508496(EXLCZ)99410000000609604820180927d2019 uy 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierImmune checkpoint inhibitors in cancer /Fumito Ito, Marc S. ErnstoffSt. Louis, Missouri :Elsevier,[2019]©20191 online resource (513 pages)Includes index.Immune checkpoint inhibitors: mechanisms and emerging therapeutic opportunities -- Immune checkpoints: melanoma and other skin cancers -- The current status of immunotherapy in thoracic malignancies -- Immune checkpoint inhibitors in gastrointestinal malignancies -- Cancers of the head and neck -- Urologic malignancies -- Gynecologic malignancies -- Breast cancer -- Hematologic malignancies -- Pediatric malignancies -- Toxicities in immune checkpoint inhibitors -- Future of immune checkpoint inhibitorsCancerImmunological aspectsCancerImmunological aspects.616.994079Ito Fumito959146Ernstoff Marc S.MiAaPQMiAaPQMiAaPQBOOK9910583389903321Immune checkpoint inhibitors in cancer2173225UNINA